Finance

Lists
Why is 000972 down 2,90%?
Dive Deeper
000972:SHE
Chalkis Health Industry Co Ltd
CNÂ¥4,02
-2,90%
(-0,12) 1D
15 Okt., 15:04:09 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000972...
Open
CNÂ¥4,09
High
CNÂ¥4,13
Low
CNÂ¥3,99
Mkt. cap
3,24 mjd
Avg. vol.
24,78 m
Volume
16,73 m
52-wk high
CNÂ¥4,81
52-wk low
CNÂ¥3,05
EPS
-CNÂ¥0,05
Shares outstanding
771,28 m
No. of employees
367
Open
CNÂ¥4,09
High
CNÂ¥4,13
Low
CNÂ¥3,99
Mkt. cap
3,24 mjd
Avg. vol.
24,78 m
Volume
16,73 m
52-wk high
CNÂ¥4,81
52-wk low
CNÂ¥3,05
EPS
-CNÂ¥0,05
Shares outstanding
771,28 m
No. of employees
367
News stories
From web sources and news partners
Profile
Xinjiang Chalkis Company Ltd is a major Chinese agricultural company that processes tomatoes and fruits, founded in 1994. It also produces conical barrels and wooden ton-boxes. It is headquartered in Urumqi, Xinjiang, China. Xinjiang Chalkis is an export-oriented state-owned enterprise that is supported and developed by the Xinjiang Production and Construction Corps, affiliated to the 6th division. It was established in May 2000 with a registered capital of 371.7 million yuan. The production facilities are mainly located in Xinjiang, Inner Mongolia and Tianjin. By the end of 2005, the company had total assets worth 2.137 billion yuan and an annual sales revenue of more than 700 million yuan. Over 95% of the company's products are exported to the international market. Since 2004, its products constitute 18% of the world's tomato sauce trading volume. Its small-can tomato sauce products account for 60% of the African market share. Since 2009, the company has heavily invested in tomato harvesting mechanization, and harvesting machine leasing is a minor revenue line. Wikipedia
About Chalkis Health Industry Co Ltd
CEO-
Employees367
Founded30 Jun. 1994
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
109,24 m
137,94 m
54,82 m
141,99 m
Cost of goods sold
124,90 m
291,69 m
53,92 m
181,88 m
Cost of revenue
124,90 m
291,69 m
53,92 m
181,88 m
Research and development expenses
505,54 k
-619,80 k
150,00 k
928,42 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24,68 m
27,17 m
13,15 m
6,21 m
Operating expense
25,07 m
23,85 m
12,75 m
9,91 m
Total operating expenses
149,96 m
315,55 m
66,67 m
191,79 m
Operating income
-40,73 m
-177,60 m
-11,85 m
-49,80 m
Other non operating income
-309,88 k
280,17 k
-598,81 k
549,93 k
EBT including unusual items
-73,12 m
96,53 m
-20,27 m
-49,25 m
EBT excluding unusual items
-50,82 m
-190,45 m
-21,14 m
-49,91 m
Income tax expense
720,07 k
1,58 m
108,79 k
-1,43 m
Effective tax rate
-0,98%
1,63%
-0,54%
2,91%
Other operating expenses
159,58 k
3,08 m
36,00 k
1,64 m
Net income
-69,38 m
97,86 m
-19,63 m
-46,29 m
Net profit margin
-63,52%
70,94%
-35,81%
-32,60%
Earnings per share
-
-
-
-
Interest and investment income
10,89 k
168,13 k
134,44 k
517,52 k
Interest expense
-9,92 m
-12,53 m
-8,83 m
-
Net interest expenses
-9,91 m
-12,37 m
-8,69 m
517,52 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-31,61 m
-168,27 m
-2,52 m
-41,19 m
Gain or loss from assets sale
2,41 m
-3,39 m
-
337,67 k
AI content may include mistakes. Learn more
Google-programme